STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to boost tumor kill while sparing healthy tissue
Disease control OngoingThis study tests a new way to give radiation to people with stage II to III non-small cell lung cancer. The goal is to deliver a higher dose directly to the tumor while keeping the dose to nearby healthy organs at standard levels. About 146 participants will receive either photon…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Targeted pill may keep ALK-Positive lung cancer from returning after surgery
Disease control OngoingThis study tests whether taking crizotinib after surgery can prevent early-stage non-small cell lung cancer from coming back in people whose tumors have a specific ALK gene change. About 166 participants who had their cancer completely removed will either take crizotinib or just …
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 14, 2026 12:06 UTC